Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized trial of methylphenidate, rivastigmine, haloperidol, or no treatment for hypoactive ICU delirium
NL-OMON31220Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of methylphenidate, rivastigmine and haloperidol in delirium (4 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Feasibility of a large randomized placebo-controlled double-blind clinical trial. Started Feb 2008; status: active, not recruiting.
02
Drugs
methylphenidaterivastigminehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON31220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31220.